(Q46682192)

English

Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

1 reference

based on heuristic

inferred from title

author name string

Mario Sánchez-Borges

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Fernan Caballero-Fonseca

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Arnaldo Capriles-Hulett

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

publication date

1 August 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

95

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

154-158

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of reactions to NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

NSAID-induced urticaria and angioedema: a reappraisal of its clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of celecoxib in individuals allergic to sulfonamide: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance induction to rofecoxib in a patient with Bartter's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961205-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)61205-7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136765

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46682192&oldid=2125961702"